Menu
GeneBe

18-50726128-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_002747.4(MAPK4):​c.1020G>A​(p.Met340Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000178 in 1,613,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

MAPK4
NM_002747.4 missense

Scores

1
9
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.75
Variant links:
Genes affected
MAPK4 (HGNC:6878): (mitogen-activated protein kinase 4) Mitogen-activated protein kinase 4 is a member of the mitogen-activated protein kinase family. Tyrosine kinase growth factor receptors activate mitogen-activated protein kinases which then translocate into the nucleus and phosphorylate nuclear targets. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011431247).
BS2
High AC in GnomAd4 at 29 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MAPK4NM_002747.4 linkuse as main transcriptc.1020G>A p.Met340Ile missense_variant 5/6 ENST00000400384.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MAPK4ENST00000400384.7 linkuse as main transcriptc.1020G>A p.Met340Ile missense_variant 5/61 NM_002747.4 P1
MAPK4ENST00000592595.5 linkuse as main transcriptc.692-3030G>A intron_variant 1
MAPK4ENST00000540640.3 linkuse as main transcriptc.387G>A p.Met129Ile missense_variant 4/52

Frequencies

GnomAD3 genomes
AF:
0.000191
AC:
29
AN:
152130
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00692
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000373
AC:
93
AN:
249498
Hom.:
0
AF XY:
0.000384
AC XY:
52
AN XY:
135376
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00765
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000883
Gnomad OTH exome
AF:
0.000825
GnomAD4 exome
AF:
0.000177
AC:
259
AN:
1461860
Hom.:
0
Cov.:
32
AF XY:
0.000169
AC XY:
123
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00715
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000360
Gnomad4 OTH exome
AF:
0.000497
GnomAD4 genome
AF:
0.000191
AC:
29
AN:
152130
Hom.:
0
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74312
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00692
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000445
Hom.:
0
Bravo
AF:
0.000230
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000354
AC:
3
ExAC
AF:
0.000272
AC:
33
EpiCase
AF:
0.000109
EpiControl
AF:
0.000356

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 02, 2021The c.1020G>A (p.M340I) alteration is located in exon 5 (coding exon 4) of the MAPK4 gene. This alteration results from a G to A substitution at nucleotide position 1020, causing the methionine (M) at amino acid position 340 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.68
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.042
T;.
Eigen
Uncertain
0.35
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.87
D;D
M_CAP
Benign
0.042
D
MetaRNN
Benign
0.011
T;T
MetaSVM
Benign
-0.35
T
MutationAssessor
Uncertain
2.2
M;.
MutationTaster
Benign
0.95
D;D;D
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.15
Sift
Uncertain
0.0050
D;D
Sift4G
Uncertain
0.058
T;D
Polyphen
0.89
P;.
Vest4
0.44
MutPred
0.40
Loss of disorder (P = 0.1075);.;
MVP
0.79
MPC
1.5
ClinPred
0.073
T
GERP RS
4.9
Varity_R
0.66
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199859025; hg19: chr18-48252498; API